Skip to main content
. 2013 Mar 15;5(3):60–67. doi: 10.4251/wjgo.v5.i3.60

Table 2.

Patient characteristics n(%)

Diagnosed Jan 2000-Dec 2004
Diagnosed Jan 2005-Dec 2008
MDT-Mix MDT-No MDT-Change MDT-Yes Other regions MDT-Mix MDT-No MDT-Change MDT-Yes Other regions
Tumor type
Oesophagus 113 (15.4) 31 (11.8) 30 (14.6) 68 (10.0) 657 (12.9) 91 (15.2) 35 (16.2) 30 (19.6) 72 (12.8) 571 (14.1)
Gastric 258 (35.2) 110 (41.8) 77 (37.6) 318 (47.0) 2146 (42.2) 214 (35.8) 73 (33.8) 45 (29.4) 240 (42.6) 1534 (38.0)
Pancreas 362 (49.4) 122 (46.4) 98 (47.8) 291 (43.0) 2278 (44.8) 293 (49.0) 108 (50.0) 78 (51.0) 252 (44.7) 1935 (47.9)
Total 733 (100.0) 263 (100.0) 205 (100.0) 677 (100.0) 5081 (100.0) 598 (100.0) 216 (100.0) 153 (100.0) 564 (100.0) 4040 (100.0)
Stage
No metastasis 109 (14.9) 38 (14.4) 28 (13.7) 81 (12.0) 694 (13.7) 59 (9.9) 30 (13.9) 28 (18.3) 71 (12.6) 543 (13.4)
Lymph node metastasis 155 (21.1) 62 (23.6) 49 (23.9) 182 (26.9) 1195 (23.5) 125 (20.9) 52 (24.1) 44 (28.8) 141 (25.0) 926 (22.9)
Distant metastasis 293 (40.0) 104 (39.5) 85 (41.5) 303 (44.8) 2083 (41.0) 237 (39.6) 97 (44.9) 57 (37.3) 237 (42.0) 1642 (40.6)
Unknown 176 (24.0) 59 (22.4) 43 (21.0) 111 (16.4) 1109 (21.8) 177 (29.6) 37 (17.1) 24 (15.7) 115 (20.4) 929 (23.0)
Total 733 (100.0) 263 (100.0) 205 (100.0) 677 (100.0) 5081 (100.0) 598 (100.0) 216 (100.0) 153 (100.0) 564 (100.0) 4040 (100.0)

MDT: Multidisciplinary team. No clinically relevant differences in stage distribution were revealed among the analyzed regions or between the two calendar periods. In addition, there were no clinically relevant differences in stage distribution among the studied counties.